DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR OXYMORPHONE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Oxymorphone Hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00225797	Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain	Completed	Endo Pharmaceuticals	Phase 3	The purpose of this study is to evaluate the analgesic efficacy and safety of oxymorphone extended release in non-cancer patients with chronic low back pain.
NCT00226395	Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain	Completed	Endo Pharmaceuticals	Phase 3	The purpose of this study is to evaluate the analgesic efficacy and safety of two doses of oxymorphone immediate release (IR) compared to placebo and oxycodone in post-surgical pain.
NCT00226421	Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain	Completed	Endo Pharmaceuticals	Phase 3	The purpose of this study is to evaluate the analgesic efficacy and safety of oxymorphone extended release in opioid-experienced patients with chronic low back pain.
NCT00260260	OXY-1: The Pharmacogenetics of Oxycodone Analgesia in Postoperative Pain	Completed	Odense University Hospital	Phase 4	Patients undergoing surgery (thyroidectomy and hysterectomy) will postoperatively receive oxycodone intravenously (IV) as pain management with morphine as an escape medicine, if there is insufficient pain relief with oxycodone. Patients' pain and side effects will be registered and after 24 hours they will answer a questionnaire. All included patients will be genotyped accordingly to CYP2D6 and relevant single nucleotide polymorphisms (SNPs), and measures of plasma levels of oxycodone will be performed.

Clinical Trial Conditions for Oxymorphone Hydrochloride

Condition Name

Condition Name for Oxymorphone Hydrochloride
Intervention	Trials
Pain	9
Chronic Pain	6
Post-operative Pain	2
Healthy	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Oxymorphone Hydrochloride
Intervention	Trials
Chronic Pain	7
Pain, Postoperative	6
Acute Pain	2
Neuralgia	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Oxymorphone Hydrochloride

Trials by Country

Trials by Country for Oxymorphone Hydrochloride
Location	Trials
United States	97
Denmark	2
Canada	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Oxymorphone Hydrochloride
Location	Trials
Texas	9
North Carolina	7
Pennsylvania	7
Florida	6
Colorado	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Oxymorphone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Oxymorphone Hydrochloride
Clinical Trial Phase	Trials
Phase 4	7
Phase 3	13
Phase 1	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Oxymorphone Hydrochloride
Clinical Trial Phase	Trials
Completed	17
Not yet recruiting	4
Recruiting	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Oxymorphone Hydrochloride

Sponsor Name

Sponsor Name for Oxymorphone Hydrochloride
Sponsor	Trials
Endo Pharmaceuticals	17
Odense University Hospital	2
Sandoz	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Oxymorphone Hydrochloride
Sponsor	Trials
Industry	22
Other	11
NIH	1

Export unavailable in trial.
Subscribe for complete access.